Safety assessment of genetically modified foods

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The development of novel foods produced through agricultural biotechnology is a complex three-stage process: gene discover, line selection, and product advancement to commercialization. The safety of genetically modified foods is an integral part of the overall developmental process throughout all of the stages. In the discovery stage, the safety of the gene, its source, and the gene products must be considered. If any questions arise at this stage, these questions must be answered later in the developmental process. During the line selection stage, the genetically modified seed progresses through a variety of greenhouse and field trials. At this stage, the biological and agronomic equivalence of the genetically modified crop to its traditional counterpart must be compared. While the evaluations made during this stage are not specifically directed toward a safety assessment, many potential products with unusual characteristics are eliminated during this stage of development. However, the elimination of products with unusual agronomic or biological characteristics enhances the likelihood that a safe product will be generated. Finally, in the pre-commercialization stage, the genetically modified product undergoes a detailed safety assessment process. This process focuses on the safety of the gene products associated with the introduced gene and any other likely toxicological or anti-nutrient factors associated with the source of the novel gene and the crop to which it was introduced. The safety of the genetically modified product for both food and feed uses is considered. Thus far, all of the genetically modified products brought into the marketplace have been subjected to such an intensive safety assessment. The safety assessment data have been reviewed by regulatory authorities around the world. The current generation of genetically modified products are quite safe for human and feed animal consumption.

Original languageEnglish (US)
Pages (from-to)178-182
Number of pages5
JournalJournal of Nematology
Volume33
Issue number4
StatePublished - Dec 1 2001

Fingerprint

genetically modified foods
safety assessment
genes
commercialization
agricultural biotechnology
novel foods
crops
field experimentation
markets
greenhouses
nutrients
seeds

Keywords

  • Allergen
  • Antibiotic resistance
  • Food safety
  • Genetic engineering
  • Safety assessment
  • Substantial equivalence
  • Toxicant

ASJC Scopus subject areas

  • Animal Science and Zoology

Cite this

Safety assessment of genetically modified foods. / Taylor, Stephen L.

In: Journal of Nematology, Vol. 33, No. 4, 01.12.2001, p. 178-182.

Research output: Contribution to journalArticle

@article{b31bffc3ca8a43e0b67c09f5f3f0fc38,
title = "Safety assessment of genetically modified foods",
abstract = "The development of novel foods produced through agricultural biotechnology is a complex three-stage process: gene discover, line selection, and product advancement to commercialization. The safety of genetically modified foods is an integral part of the overall developmental process throughout all of the stages. In the discovery stage, the safety of the gene, its source, and the gene products must be considered. If any questions arise at this stage, these questions must be answered later in the developmental process. During the line selection stage, the genetically modified seed progresses through a variety of greenhouse and field trials. At this stage, the biological and agronomic equivalence of the genetically modified crop to its traditional counterpart must be compared. While the evaluations made during this stage are not specifically directed toward a safety assessment, many potential products with unusual characteristics are eliminated during this stage of development. However, the elimination of products with unusual agronomic or biological characteristics enhances the likelihood that a safe product will be generated. Finally, in the pre-commercialization stage, the genetically modified product undergoes a detailed safety assessment process. This process focuses on the safety of the gene products associated with the introduced gene and any other likely toxicological or anti-nutrient factors associated with the source of the novel gene and the crop to which it was introduced. The safety of the genetically modified product for both food and feed uses is considered. Thus far, all of the genetically modified products brought into the marketplace have been subjected to such an intensive safety assessment. The safety assessment data have been reviewed by regulatory authorities around the world. The current generation of genetically modified products are quite safe for human and feed animal consumption.",
keywords = "Allergen, Antibiotic resistance, Food safety, Genetic engineering, Safety assessment, Substantial equivalence, Toxicant",
author = "Taylor, {Stephen L}",
year = "2001",
month = "12",
day = "1",
language = "English (US)",
volume = "33",
pages = "178--182",
journal = "Journal of Nematology",
issn = "0022-300X",
publisher = "Society of Nematologists",
number = "4",

}

TY - JOUR

T1 - Safety assessment of genetically modified foods

AU - Taylor, Stephen L

PY - 2001/12/1

Y1 - 2001/12/1

N2 - The development of novel foods produced through agricultural biotechnology is a complex three-stage process: gene discover, line selection, and product advancement to commercialization. The safety of genetically modified foods is an integral part of the overall developmental process throughout all of the stages. In the discovery stage, the safety of the gene, its source, and the gene products must be considered. If any questions arise at this stage, these questions must be answered later in the developmental process. During the line selection stage, the genetically modified seed progresses through a variety of greenhouse and field trials. At this stage, the biological and agronomic equivalence of the genetically modified crop to its traditional counterpart must be compared. While the evaluations made during this stage are not specifically directed toward a safety assessment, many potential products with unusual characteristics are eliminated during this stage of development. However, the elimination of products with unusual agronomic or biological characteristics enhances the likelihood that a safe product will be generated. Finally, in the pre-commercialization stage, the genetically modified product undergoes a detailed safety assessment process. This process focuses on the safety of the gene products associated with the introduced gene and any other likely toxicological or anti-nutrient factors associated with the source of the novel gene and the crop to which it was introduced. The safety of the genetically modified product for both food and feed uses is considered. Thus far, all of the genetically modified products brought into the marketplace have been subjected to such an intensive safety assessment. The safety assessment data have been reviewed by regulatory authorities around the world. The current generation of genetically modified products are quite safe for human and feed animal consumption.

AB - The development of novel foods produced through agricultural biotechnology is a complex three-stage process: gene discover, line selection, and product advancement to commercialization. The safety of genetically modified foods is an integral part of the overall developmental process throughout all of the stages. In the discovery stage, the safety of the gene, its source, and the gene products must be considered. If any questions arise at this stage, these questions must be answered later in the developmental process. During the line selection stage, the genetically modified seed progresses through a variety of greenhouse and field trials. At this stage, the biological and agronomic equivalence of the genetically modified crop to its traditional counterpart must be compared. While the evaluations made during this stage are not specifically directed toward a safety assessment, many potential products with unusual characteristics are eliminated during this stage of development. However, the elimination of products with unusual agronomic or biological characteristics enhances the likelihood that a safe product will be generated. Finally, in the pre-commercialization stage, the genetically modified product undergoes a detailed safety assessment process. This process focuses on the safety of the gene products associated with the introduced gene and any other likely toxicological or anti-nutrient factors associated with the source of the novel gene and the crop to which it was introduced. The safety of the genetically modified product for both food and feed uses is considered. Thus far, all of the genetically modified products brought into the marketplace have been subjected to such an intensive safety assessment. The safety assessment data have been reviewed by regulatory authorities around the world. The current generation of genetically modified products are quite safe for human and feed animal consumption.

KW - Allergen

KW - Antibiotic resistance

KW - Food safety

KW - Genetic engineering

KW - Safety assessment

KW - Substantial equivalence

KW - Toxicant

UR - http://www.scopus.com/inward/record.url?scp=0035528332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035528332&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 178

EP - 182

JO - Journal of Nematology

JF - Journal of Nematology

SN - 0022-300X

IS - 4

ER -